Portfolio Update
EMV Capital plc announced a virtual "Meet the Portfolio" event scheduled for February 26, 2026, at 02:00 p.m. to provide investors with insights into two of its portfolio companies, Vortex, a leader in liquid biopsy technologies for precision oncology, and DName-iT, a MedTech company utilizing patented DNA barcoding for specimen labelling. The event, hosted on the Investor Meet Company platform, will feature presentations from the respective companies' leadership and EMV Capital's CEO, with questions able to be submitted in advance or during the live session. No inside information will be disclosed, adhering to UK Market Abuse Regulation.
Select text to share a quote on X · sign in to keep highlights & notes in your EMVC notes
As part of its ongoing investor engagement programme, EMV Capital plc (AIM: EMVC), the deep tech and life sciences VC investment group, is pleased to announce that it will host a virtual Meet the Portfolio event on 26 February 2026 at 02.00 p.m. The session will provide investors with greater insight into two of its portfolio companies, Vortex and DName-iT.
Virtual Meet the Portfolio - Vortex and DName-iT
The online event will take place via the Investor Meet Company platform and will be hosted by Dr Ilian Iliev, CEO of EMV Capital plc, who will be joined by:
- The Managing Director of Vortex, a leader in liquid biopsy technologies for precision oncology; and
- The CEO of DName-iT, a MedTech company applying its patented DNA barcoding method to develop a platform for labelling patients' specimens that are analysed with Next Generation Sequencing.
This presentation is open to all interested parties. Anyone can sign up for free and join the live presentation via:
Questions can be submitted pre-event via your Investor Meet Company dashboard up until 25 February 2026 at 09:00 a.m., or at any time during the live presentation.
In accordance with UK Market Abuse Regulation (UK MAR), no inside information will be disclosed during the event.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.